v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative-effect adjustment from adoption of ASU 2020-06
Restricted Stock Units
Common Stock
Common Stock
Restricted Stock Units
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative-effect adjustment from adoption of ASU 2020-06
Additional Paid-in Capital
Restricted Stock Units
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of ASU 2020-06
Beginning balance (in shares) at Jan. 31, 2021       278,363              
Beginning balance at Jan. 31, 2021 $ 750,006     $ 28   $ 2,307,580     $ 7,410 $ (1,565,012)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       3,983              
Issuance of common stock upon exercise of stock options 33,573         33,573          
Stock-based compensation expense 209,401         209,401          
Vesting of restricted stock units (in shares)         9,875            
Vesting of restricted stock units     $ 0   $ 1     $ (1)      
Tax withholding on vesting of restricted stock units (in shares)       (386)              
Tax withholding on vesting of restricted stock units (8,670)         (8,670)          
Forfeiture of restricted stock (in shares)       (62)              
Forfeiture of restricted stock 0                    
Common stock issued under employee stock purchase plan (in shares)       4,365              
Common stock issued under employee stock purchase plan 36,641         36,641          
Repurchases of common stock (in shares)       (6,057)              
Repurchases of common stock (130,608)         (130,608)          
Other comprehensive loss (7,717)               (7,717)    
Net loss (158,202)                 (158,202)  
Ending balance (in shares) at Oct. 31, 2021       290,081              
Ending balance at Oct. 31, 2021 724,424     $ 29   2,447,916     (307) (1,723,214)  
Beginning balance (in shares) at Jan. 31, 2021       278,363              
Beginning balance at Jan. 31, 2021 750,006     $ 28   2,307,580     7,410 (1,565,012)  
Ending balance (in shares) at Feb. 06, 2022       292,633              
Ending balance at Feb. 06, 2022 $ 754,336 $ (35,127)   $ 29   2,470,943 $ (133,265)   (8,365) (1,708,271) $ 98,138
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                    
Beginning balance (in shares) at Aug. 01, 2021       284,734              
Beginning balance at Aug. 01, 2021 $ 697,444     $ 28   2,388,418     3,481 (1,694,483)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       2,086              
Issuance of common stock upon exercise of stock options 22,289         22,289          
Stock-based compensation expense 76,616         76,616          
Vesting of restricted stock units (in shares)         3,548            
Vesting of restricted stock units     0   $ 1     (1)      
Tax withholding on vesting of restricted stock units (in shares)       (81)              
Tax withholding on vesting of restricted stock units (2,106)         (2,106)          
Forfeiture of restricted stock (in shares)       (25)              
Forfeiture of restricted stock 0                    
Common stock issued under employee stock purchase plan (in shares)       2,180              
Common stock issued under employee stock purchase plan 18,915         18,915          
Repurchases of common stock (in shares)       (2,361)              
Repurchases of common stock (56,215)         (56,215)          
Other comprehensive loss (3,788)               (3,788)    
Net loss (28,731)                 (28,731)  
Ending balance (in shares) at Oct. 31, 2021       290,081              
Ending balance at Oct. 31, 2021 724,424     $ 29   2,447,916     (307) (1,723,214)  
Beginning balance (in shares) at Feb. 06, 2022       292,633              
Beginning balance at Feb. 06, 2022 754,336 $ (35,127)   $ 29   2,470,943 $ (133,265)   (8,365) (1,708,271) $ 98,138
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       2,316              
Issuance of common stock upon exercise of stock options 19,139         19,139          
Stock-based compensation expense 246,677         246,677          
Vesting of restricted stock units (in shares)         10,632            
Vesting of restricted stock units     0   $ 1     $ (1)      
Tax withholding on vesting of restricted stock units (in shares)       (517)              
Tax withholding on vesting of restricted stock units (16,130)         (16,130)          
Common stock issued under employee stock purchase plan (in shares)       3,014              
Common stock issued under employee stock purchase plan 39,965         39,965          
Repurchases of common stock (in shares)       (5,409)              
Repurchases of common stock (151,564)         (151,564)          
Other comprehensive loss (15,388)               (15,388)    
Net loss (1,400)                 (1,400)  
Ending balance (in shares) at Nov. 06, 2022       302,669              
Ending balance at Nov. 06, 2022 840,508     $ 30   2,475,764     (23,753) (1,611,533)  
Beginning balance (in shares) at Aug. 07, 2022       298,801              
Beginning balance at Aug. 07, 2022 761,358     $ 30   2,392,173     (20,099) (1,610,746)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       459              
Issuance of common stock upon exercise of stock options 3,878         3,878          
Stock-based compensation expense 86,852         86,852          
Vesting of restricted stock units (in shares)         3,482            
Vesting of restricted stock units     $ 0                
Tax withholding on vesting of restricted stock units (in shares)       (112)              
Tax withholding on vesting of restricted stock units (3,143)         (3,143)          
Common stock issued under employee stock purchase plan (in shares)       927              
Common stock issued under employee stock purchase plan 20,569         20,569          
Repurchases of common stock (in shares)       (888)              
Repurchases of common stock (24,565)         (24,565)          
Other comprehensive loss (3,654)               (3,654)    
Net loss (787)                 (787)  
Ending balance (in shares) at Nov. 06, 2022       302,669              
Ending balance at Nov. 06, 2022 $ 840,508     $ 30   $ 2,475,764     $ (23,753) $ (1,611,533)